Renocrit 4000 IU Injection – Erythropoietin Alfa for Anemia Management

Renocrit 4000 IU Injection (Epoetin Alfa) treats anemia caused by chronic kidney disease, cancer chemotherapy, or HIV therapy. Stimulates red blood cell production to reduce fatigue and transfusion needs. Prescription required.

Key Features:

Active ingredient: Recombinant human erythropoietin alfa (Epoetin Alfa)

Dose: 4000 IU per pre-filled syringe

Indications: Anemia from CKD, cancer chemotherapy, or HIV (zidovudine) treatment

Route: Subcutaneous injection (abdomen, thigh, or upper arm)

Prescription Only Medicine

Storage: Refrigerate at 2°C to 8°C, protect from light, do not freeze

Supplied in sterile pre-filled syringes

Detailed Description:
Renocrit 4000 IU Injection is an erythropoiesis-stimulating agent (ESA) used to manage anemia by encouraging the bone marrow to produce more red blood cells. This improves oxygen delivery throughout the body, helping to reduce symptoms such as fatigue and weakness.
It is prescribed for:

Anemia due to chronic kidney disease (CKD)

Anemia caused by cancer chemotherapy

Anemia from HIV infection treated with zidovudine
It may also be used to reduce the need for blood transfusions in patients at high risk of blood loss before surgery.

Renocrit is not suitable for patients with uncontrolled hypertension, certain blood disorders, or hypersensitivity to its components. Use with caution in patients with a history of blood clots, heart disease, stroke, liver disease, or cancer.

Possible Side Effects:

Common: Headache, nausea, vomiting, diarrhea, muscle cramps, injection site pain or swelling, fatigue, dizziness, chills, fever

Serious: Blood clots, stroke, heart attack, high blood pressure, seizures, allergic reactions, liver or kidney problems

Storage & Handling:

Store at 2°C to 8°C

Do not freeze

Keep in original packaging to protect from light

Keep away from children

Disclaimer:
This product is for use under medical supervision only. Always follow your doctor’s instructions and do not self-inject unless properly trained. Consult your healthcare provider if you are pregnant, breastfeeding, or have underlying health conditions.